3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
2
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Surgical Wound Infection
1
Neuroma, Acoustic
1
Breast Neoplasms
1
Interventions
Cochlear Implants
3
Radiosurgery
2
Lapatinib
2
Everolimus
2
Bevacizumab
2
tozuleristide
1
icotinib
1
Triamcinolone Acetonide
1
Temozolomide
1
Sirolimus
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Mn-PyC3A
1
Microsurgery
1
Methylprednisolone
1
Gentamicins
1
Fluoresceins
1
Fluorescein
1
Exome
1
Endostatins
1
Axitinib
1
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Neuroma, Acoustic
×
Gentamicins
×
Clear all
NCT02963896
2016-11-15
ITG
University Hospital, Motol
Phase NA
Completed
20 enrolled